Factors associated with use of HIV primary care among persons recently diagnosed with HIV: Examination of variables from the behavioural model of health-care utilization

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 2, 2007, Pages 195-202

  Anthony, M N ^a,b   Gardner, L ^b   Marks, G ^b   Anderson Mahoney, P ^c   Metsch, L R ^d   Valverde, E E ^d   Rio, C Del ^e   Loughlin, A M ^f  

^a NORTHROP GRUMMAN CORPORATION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Health Research Association   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; GENERAL ASPECTS OF DISEASE; HEALTH CARE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; PRIMARY HEALTH CARE;

EID: 33847013311     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120600966182     Document Type: Article

References (41)

1. Andersen, R.M. (1995). Revisiting the behavioral model and access to medical care: does it matter? Journal of Health and Social Behaviour, Mar 36, 1-10.
2. Andersen, R., Bozzette, S., Shapiro, M., St. Clair, P., Morton, S., et al. (2000). Access of vulnerable groups to Antiretroviral Therapy among persons in care for HIV disease in the United States. Health Services Research, 2, 389-416.
3. Antela, A. (2001). Access to antiretroviral therapy in HIV-infected drug users. AIDS, 15, 1727-28.
4. Bandura, A. (1986). Social foundations of thought and action. Englewood Cliffs, NJ: Prentice Hall.
5. Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., Kaiser, L., et al. (1999). Why is antiretroviral therapy (HAART) not prescribed or discontinued? Journal of Acquired Immune Deficiency Syndromes, 21, 114-19.
6. Bing, E., Kilbourne, A., Brooks, R., Lazarus, E., & Senak, M. (1999). Protease inhibitor use among a community sample of people with HIV disease. Journal of Acquired Immune Deficiency Syndromes, 20, 474-80.
7. Bozzette, S.A., Hays, R.D., Berry, S.H., & Kanouse, D.E. (1994). A perceived health index for use in persons with advanced HIV disease : derivation, reliability, and validity. Medical Care, 32, 716-31.
8. Centers for Disease Control & Prevention, MMWR Weekly (2003) Late versus early testing of HIV - 16 sites, United States, 2000-2003. Morbidity and Mortality Weekly Report, 52, 581-86.
9. Center for Disease Control and Prevention, HIV Prevention Strategic Plan through 2005. (2001). http://www.cdc.gov/hiv/pubs/prev-strat-plan.pdf.
10. Celentano, D., Galai, N., Sethi, A., Shah, N., Strathdee, S., Vlahov, D., & Gallant, J. (2001). Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS, 15, 1707-15.
11. Chadborn, R., Baster, K., Delpech, V., Sabin, C., Sinka, K., Rice, B., & Evans, B. (2005). No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? AIDS, 19, 513-20.
12. Cunningham, W.E., Andersen, R.M., Katz, M.H., Stein, M.D., Turner, B.J., Crystal, S., et al. (1999). The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Medical Care, 37, 1270-81.
13. Cunningham, Terry. Electronic mail correspondence. January 2005.
14. Fairfield, K., Libman, H., Davis, R., Eisenberg, D., & Phillips, R. (1999). Delays in protease inhibitor use in clinical practice. Journal of General Internal Medicine, 14, 395-401.
15. Fleming, P.L., Byers, R. H., Sweeney, P.A., Daniels, D., Karon, J.M., & Janssen, R.S. (2002). HIV Prevalence in the United States in 2002. Abstract 11 (pp. 56). IX Conference on Retroviruses and Opportunistic Infections. Seattle, Washington.
16. Gardner, L. I., Metsch, L. R., Anderson-Mahoney, P., Loughlin, A.M., del Rio, C., Strathdee, S., et al. (2005). Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS, 19, 423-31.
17. Giordano, T.P., White, A.C. Jr, Sajja, P., Graviss, E.A., & Arduino, R.C. et al. (2003). Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. Journal of Acquired Immune Deficiency Syndromes, 32, 399-405.
18. Girardi, E., Aloisi, M., Arici, C., Pezzotti, P., Serraino, D., Balzano, R., et al. (2004). Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. Journal of Acquired Immune Deficiency Syndromes, 36, 951-59.
19. Glynn, M. & Rhodes, P. (2005). Estimated HIV prevalence in the United States at the end of 2003. 2005 National HIV Prevention Conference, Atlanta, GA, June 12-15, Abstract T1-B11-13 (p. 85).
20. Henry J. Kaiser Family Foundation (1999). Medicaid and HIV/ AIDS Policy: A basic primer. KFF report Number 2136 (Henry J. Kaiser Family Foundation, Inc, Menlo Park, CA).
21. Ickovics, J., Hamburger, M., Vlahov, D., Schoenbaum, E., Schuman, P., et al. (2001). Mortality, CD4 cell count decline and depressive symptoms among HIV-seropositive women. Journal of the American Medical Association, 285, 1466-74.
22. Institute of Medicine (2004). Public financing and delivery of HIV/ AIDS care: Securing the legacy of Ryan White. Washington D.C.: National Academies Press. pp. 153.
23. Johnson, D., Sorvillo, F., Wohl, A., Bunch, G., Harawa, N., Carruth, A., Castillon, M., & Jimenez, B. (2003). Frequent failed early HIV detection in a high prevalence area: implications for prevention. AIDS Patient Care and STDs, 17, 277-82.
24. Justice, A., Holmes, W., Gifford, A., Rabeneck, L., Zackin, R., Sinclair, G., et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77-S90.
25. Krawczyk, C.S., Gardner, L.I., Wang, J., Sadek, R., Loughlin, A.M., et al. (2003). Antiretroviral Treatment and Access Study Group. Test-retest reliability of a complex human immunodeficiency virus research questionnaire administered by an Audio Computer-assisted Self-interviewing system. Medical Care, Jul, 41, 853-58.
26. Laine, C., Hauck, W., & Turner, B. Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users (2002). Medical Care, 40, 976-95.
27. Murri, R., Fantoni, M., Del Borgo, C., Izzi, I., Visonà, R, et al. (1999). Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. Journal of Acquired Immune Deficiency Syndromes, 22, 461-66.
28. Quinn, T.C., Wawer, M.J., Sewankambo, N., et al. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine, 342, 921-29.
29. Rapp, R.C., Siegal, H.A., Li, L., & Saha, P. (1998). Predicting postprimary treatment services and drug use outcomes: a multivariate analysis. American Journal of Drug and Alcohol Abuse, 24, 603-15.
30. Rothman, K., & Greenland, S. (1998). Modern Epidemiology: second edition. Lippencott-Raven publishers. Philadelphia, pp. 257.
31. Sacks, S. (2000). Co-occurring mental and substance use disorders: promising approaches and research issues. Substance Use and Misuse, 35, 2061-93.
32. Saleebey, D. (1997). The Strengths Perspective in Social Work Practice, Second Edition. Longman Publishers. New York.
33. Samet, J.H., Freedberg, K.A., Stein, M.D., Lewis, R., Savetsky, J., Sullivan, L., et al. (1998). Trillion virion delay: Time from testing positive for HIV to presentation for primary care. Archives of Internal Medicine, 158, 734-40.
34. Sorvillo, F., Kerndt, P., Odom, S., Castillon, M., Carruth, A., & Contreras, R. (1999). Use of protease inhibitors among persons with AIDS in Los Angeles County. AIDS Care, 11, 147-55.
35. Tovanabutra, S., Wongtrakul, J., Sennum, S., et al. (2002). Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. Journal of Acquired Immune Deficiency Syndromes, 29, 275-83.
36. Turner, B., Cunningham, W., Duan, N., Andersen, R., Shapiro, M., et al. (2000). Delayed medical care after diagnosis in a U.S. national probability sample of persons infected with human immunodeficiency virus. Archives of Internal Medicine, 160, 2614-22.
37. Walensky, R., Losina, E., Malatesta, L., Barton, G., O'Connor, A, et al. (2005). Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. American Journal of Public Health, 95, 71-73.
38. Walensky, R., Weinstein, M., Smith, H., Freedberg, K., & Paltiel, D. (2005). Optimal allocation of testing dollars: the example of HIV counseling, testing and referral. Medical Decision Making, May/June, 25, 321-29.
39. Weil, A. (2003). There's something about Medicaid. Health Affairs, 22, 13-30.
40. Wiewel, E., Bennani, Y., Ramaswamy, C., Sackoff, J.E., & Torian, L.V. (2004). High prevalence and late diagnosis of HIV among black men aged 40-54 in New York City. The XV International AIDS Conference, July 11, abstract MoPeC3506. Bangkok, Thailand.
41. Zimmerman MA. Psychological empowerment: issues and illustrations (1995). American Journal of Community Psychology, 23, 581-99.